Impact of Thromboprophylaxis Intensity on Patients’ Mortality Among Hospitalized Patients with COVID-19: A Propensity-Score Matched Study

References

• Sridharan GK, Vegunta R, Rokkam VRP, et al. Venous thromboembolism in hospitalized COVID-19 patients. Am J Ther. 2020;27(6):e599–e610. doi:10.1097/mjt.0000000000001295
   PubMed Web of Science ®Google Scholar
• Jiménez D, García-Sanchez A, Rali P, et al. Incidence of VTE and bleeding among hospitalized patients with Coronavirus Disease 2019: a systematic review and meta-analysis. Chest. 2021;159(3):1182–1196. doi:10.1016/j.chest.2020.11.005
   PubMed Web of Science ®Google Scholar
• Porfidia A, Valeriani E, Pola R, et al. Venous thromboembolism in patients with COVID-19: systematic review and meta-analysis. Thromb Res. 2020;196:67–74. doi:10.1016/j.thromres.2020.08.020
   PubMed Web of Science ®Google Scholar
• Nopp S, Moik F, Jilma B, et al. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178–1191. doi:10.1002/rth2.12439
   PubMed Web of Science ®Google Scholar
• Mansory EM, Srigunapalan S, Lazo-Langner A. Venous thromboembolism in hospitalized critical and noncritical COVID-19 patients: a systematic review and meta-analysis. TH Open. 2021;5(3):e286–e294. doi:10.1055/s-0041-1730967
   PubMedGoogle Scholar
• Spyropoulos AC, Bonaca MP. Studying the coagulopathy of COVID-19. Lancet. 2021. doi:10.1016/S0140-6736(21)01906-1
   Web of Science ®Google Scholar
• Lowenstein CJ, Solomon SD. Severe COVID-19 is a microvascular disease. Circulation. 2020;142(17):1609–1611. doi:10.1161/CIRCULATIONAHA.120.050354
   PubMed Web of Science ®Google Scholar
• Ma L, Sahu SK, Cano M, et al. Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection. Sci Immunol. 2021;6(59). doi:10.1126/sciimmunol.abh2259
   Web of Science ®Google Scholar
• Connors JM, Levy JH. Thromboinflammation and the hypercoagulability of COVID-19. J Thromb Haemost. 2020;18(7):1559–1561. doi:10.1111/jth.14849
   PubMed Web of Science ®Google Scholar
• Nadkarni GN, Lala A, Bagiella E, et al. Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(16):1815–1826. doi:10.1016/j.jacc.2020.08.041
   PubMed Web of Science ®Google Scholar
• Rentsch CT, Beckman JA, Tomlinson L, et al. Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study. BMJ. 2021;372:n311. doi:10.1136/bmj.n311
   PubMed Web of Science ®Google Scholar
• Ferguson J, Volk S, Vondracek T, et al. Empiric therapeutic anticoagulation and mortality in critically ill patients with respiratory failure from SARS-CoV-2: a retrospective cohort study. J Clin Pharmacol. 2020;60(11):1411–1415. doi:10.1002/jcph.1749
   Web of Science ®Google Scholar
• Motta JK, Ogunnaike RO, Shah R, et al. Clinical outcomes with the use of prophylactic versus therapeutic anticoagulation in Coronavirus Disease 2019. Crit Care Explor. 2020;2(12):e0309. doi:10.1097/cce.0000000000000309
   PubMedGoogle Scholar
• Helms J, Severac F, Merdji H, et al. Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-Center cohort study. Ann Intensive Care. 2021;11(1):14. doi:10.1186/s13613-021-00809-5
   Web of Science ®Google Scholar
• Hsu A, Liu Y, Zayac AS, et al. Intensity of anticoagulation and survival in patients hospitalized with COVID-19 pneumonia. Thromb Res. 2020;196:375–378. doi:10.1016/j.thromres.2020.09.030
   Web of Science ®Google Scholar
• Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. J Am Coll Cardiol. 2020;76(1):122–124. doi:10.1016/j.jacc.2020.05.001
   PubMed Web of Science ®Google Scholar
• Al-Samkari H, Gupta S, Leaf RK, et al. Thrombosis, bleeding, and the observational effect of early therapeutic anticoagulation on survival in critically ill patients with COVID-19. Ann Intern Med. 2021;174(5):622–632. doi:10.7326/m20-6739
   PubMed Web of Science ®Google Scholar
• Moll M, Zon RL, Sylvester KW, et al. Intermediate versus standard dose heparin prophylaxis in COVID-19 ICU patients: a propensity score-matched analysis. Thromb Res. 2021;203:57–60. doi:10.1016/j.thromres.2021.04.009
   Web of Science ®Google Scholar
• Meizlish ML, Goshua G, Liu Y, et al. Intermediate-dose anticoagulation, aspirin, and in-hospital mortality in COVID-19: a propensity score-matched analysis. Am J Hematol. 2021;96(4):471–479. doi:10.1002/ajh.26102
   PubMed Web of Science ®Google Scholar
• Cuker A, Tseng EK, Nieuwlaat R, et al. American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19. Blood Adv. 2021;5(3):872–888. doi:10.1182/bloodadvances.2020003763
   PubMed Web of Science ®Google Scholar
• Moores LK, Tritschler T, Brosnahan S, et al. Prevention, diagnosis, and treatment of VTE in patients with Coronavirus Disease 2019: CHEST guideline and expert panel report. Chest. 2020;158(3):1143–1163. doi:10.1016/j.chest.2020.05.559
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Levy JH, Ageno W, et al. Scientific and Standardization Committee communication: clinical guidance on the diagnosis, prevention, and treatment of venous thromboembolism in hospitalized patients with COVID-19. J Thromb Haemost. 2020;18(8):1859–1865. doi:10.1111/jth.14929
   PubMed Web of Science ®Google Scholar
• National Institutes of Health: COVID-19 Treatment Guidelines Panel. COVID-19 treatment guidelines: antithrombotic therapy in patients with COVID-19; 2021. Available from: https://www.covid19treatmentguidelines.nih.gov/therapies/antithrombotic-therapy/. Accessed January 9, 2022.
   Google Scholar
• Sadeghipour P, Talasaz AH, Rashidi F, et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized clinical trial. JAMA. 2021;325(16):1620–1630. doi:10.1001/jama.2021.4152
   Web of Science ®Google Scholar
• Perepu US, Chambers I, Wahab A, et al. Standard prophylactic versus intermediate dose enoxaparin in adults with severe COVID-19: a multi-center, open-label, randomized controlled trial. J Thromb Haemost. 2021;19(9):2225–2234. doi:10.1111/jth.15450
   PubMed Web of Science ®Google Scholar
• Spyropoulos AC, Goldin M, Giannis D, et al. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19: the HEP-COVID randomized clinical trial. JAMA Intern Med. 2021;181(12):1612–1620. doi:10.1001/jamainternmed.2021.6203
   PubMed Web of Science ®Google Scholar
• Sholzberg M, Tang GH, Rahhal H, et al. Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial. BMJ. 2021;375:n2400. doi:10.1136/bmj.n2400
   Google Scholar
• Lawler PR, Goligher EC, Berger JS, et al. Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19. N Engl J Med. 2021;385(9):790–802. doi:10.1056/NEJMoa2105911
   Web of Science ®Google Scholar
• Goligher EC, Bradbury CA, McVerry BJ, et al. Therapeutic anticoagulation with heparin in critically ill patients with Covid-19. N Engl J Med. 2021;385(9):777–789. doi:10.1056/NEJMoa2103417
   PubMed Web of Science ®Google Scholar
• SAS Institute Inc. The PSMATCH Procedure. SAS/STAT^® 142 User’s Guide. Cary, NC.: SAS Institute Inc.; 2016.
   Google Scholar
• Pan W, Bai H. Propensity score methods for causal inference: an overview. Behaviormetrika. 2018;45(2):317–334. doi:10.1007/s41237-018-0058-8
   Google Scholar
• Armstrong RA, Kane AD, Cook TM. Outcomes from intensive care in patients with COVID-19: a systematic review and meta-analysis of observational studies. Anaesthesia. 2020;75(10):1340–1349. doi:10.1111/anae.15201
   PubMed Web of Science ®Google Scholar